Article info

PDF

Review
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper

Authors

  • Paul Abraham Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Diego A Arroyo Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, SwitzerlandDepartment of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland PubMed articlesGoogle scholar articles
  • Raphael Giraud Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Henri Bounameaux Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Karim Bendjelid Intensive Care Unit, Geneva University Hospitals, Geneva, SwitzerlandGeneva Hemodynamic Research Group, Geneva, Switzerland PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Karim Bendjelid; karim.bendjelid{at}hcuge.ch
View Full Text

Citation

Abraham P, Arroyo DA, Giraud R, et al
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper

Publication history

  • Received October 11, 2017
  • Revision received January 23, 2018
  • Accepted January 30, 2018
  • First published February 26, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.